A Long-Term, Single-Arm, Open-label, Multicenter Phase 3 Study to Evaluate the Safety
Clinical Trial Grant
Administered By
School of Medicine
Awarded By
Argenx BVBA
Start Date
September 14, 2021
End Date
September 13, 2026
Administered By
School of Medicine
Awarded By
Argenx BVBA
Start Date
September 14, 2021
End Date
September 13, 2026